{{Distinguish|Methoxetamine}}
{{Chembox
| ImageFile = Methoxyketamine.svg
| ImageSize = 150px
| ImageAlt =
| IUPACName = 2-(2-Methoxyphenyl)-2-(methylamino)cyclohexanone
| OtherNames =
|Section1={{Chembox Identifiers
| CASNo = 7063-51-6
| CASNo_Ref = {{cascite|correct|}}
| CASNo1 = 6728-62-7 
| CASNo1_Comment =([[hydrochloride|HCl]])
| PubChem =
| ChemSpiderID = 27470964
| SMILES = CNC1(CCCCC1=O)c2ccccc2OC
| InChI = 1/C14H19NO2/c1-15-14(10-6-5-9-13(14)16)11-7-3-4-8-12(11)17-2/h3-4,7-8,15H,5-6,9-10H2,1-2H3
| InChIKey = OYAUVHORXFUVAJ-UHFFFAOYAM
| StdInChI = 1S/C14H19NO2/c1-15-14(10-6-5-9-13(14)16)11-7-3-4-8-12(11)17-2/h3-4,7-8,15H,5-6,9-10H2,1-2H3
| StdInChIKey = OYAUVHORXFUVAJ-UHFFFAOYSA-N
}}
|Section2={{Chembox Properties
| C=14 | H=19 | N=1 | O=2
| Appearance =
| Density =
| MeltingPt =
| BoilingPt =
| Solubility = }}
|Section3={{Chembox Hazards
| MainHazards =
| FlashPt =
| AutoignitionPt = }}
}}

'''Methoxyketamine''' or '''2-MeO-2-deschloroketamine''' is a [[designer drug]] of the [[arylcyclohexylamine]] class first reported in 1963.<ref>{{ cite patent | country = BE | number = 634208 | title = Amino ketones | pubdate = 1963 | inventor = Stevens, Calvin L.}}</ref> It is an [[analog (chemistry)|analog]] of [[ketamine]] in which the chlorine atom has been replaced with a [[methoxy group]].  Its synthesis by rearrangement of an amino ketone has been reported.<ref>{{cite journal | doi = 10.1021/jo01346a034 | title = Amino Ketone Rearrangements. VII.1 Synthesis of 2-Methylamino-2-Substituted Phenylcyclohexanones | year = 1966 | last1 = Stevens | first1 = Calvin L. | last2 = Thuillier | first2 = Andre | last3 = Taylor | first3 = K. Grant | last4 = Daniher | first4 = Francis A. | last5 = Dickerson | first5 = James P. | last6 = Hanson | first6 = Harry T. | last7 = Nielsen | first7 = Norman A. | last8 = Tikotkar | first8 = N. A. | last9 = Weier | first9 = Richard M. | journal = The Journal of Organic Chemistry | volume = 31 | issue = 8 | pages = 2601 }}</ref> As an arylcyclohexylamine, methoxyketamine most likely functions as an [[NMDA receptor antagonist]]. It may produce sedative, hallucinogenic, and (at high doses) anesthetic effects.

==References==
{{Reflist}}


{{Hallucinogens}}
{{Glutamate receptor modulators}}

[[Category:Amines]]
[[Category:Designer drugs]]
[[Category:Dissociative drugs]]
[[Category:Ketones]]
[[Category:Phenol ethers]]


{{organic-compound-stub}}